Image

The Norwegian Immunotherapy in Multiple Myeloma Study

The Norwegian Immunotherapy in Multiple Myeloma Study

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The goal of this observational study is to study the effectiveness and complications of novel immunotherapies used in the treatment of multiple myeloma in routine care in Norway. The aim is to close knowledge gaps, generate evidence for future clinical trials and contribute to future consensus on how to monitor for adverse events, and what mitigation strategies should be implemented, so that we can increase patient survival and quality-of-life.

Eligibility

Inclusion criteria

  • Participants age ≥ 18 years
  • Prior diagnosis of one of the following
    • Multiple myeloma as defined according to IMWG criteria
    • Primary plasma cell leukemia as defined according to IMWG consensus definition
    • AL-amyloidosis as defined according to IMWG criteria
  • Planned treatment with one of the following outside clinical trials (list to be

    amended based on approvals within the EU):

    • Teclistamab (Tecvayli)
    • Elranatamab (Elrexfio)
    • Talquetamab (Talvey)
    • Idecabtagene vicleucel (ide-cel/Abecma)
    • Ciltacabtagene autoleucel (cilta-cel/Carvykti)

Exclusion Criteria:

  • None

Study details
    Myeloma Multiple
    Plasma Cell Leukemia
    AL Amyloidosis

NCT06855121

St. Olavs Hospital

4 September 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.